| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/31/1995 | US5385736 Sheet with coating of melatonin, carbitol and pressure sensitive adhesive containing terpolymers of acrylic esters, (substituted)acrylamides or N-vinylpyrrolidone/2-/, with vinyl acetate |
| 01/31/1995 | US5385735 Semduramicin premix |
| 01/31/1995 | US5385720 X-ray radiology and computer tomography; uniform coating of the soft tissues; medical diagnosis |
| 01/31/1995 | CA1334224C Polymeric materials made from destructurized starch and at least one synthetic thermoplastic polymeric material |
| 01/29/1995 | CA2128954A1 Spermicidal anti-viral lubricant composition and method of using same |
| 01/26/1995 | WO1995002686A1 Redirection of cellular immunity by receptor chimeras |
| 01/26/1995 | WO1995002423A1 Metal radionuclide labeled proteins for diagnosis and therapy |
| 01/26/1995 | WO1995002421A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| 01/26/1995 | WO1995002420A2 Prodrugs of protein tyrosine kinase inhibitors |
| 01/26/1995 | WO1995002411A1 Stabilised polypeptide growth factor formulation at low ph |
| 01/26/1995 | WO1995002404A1 Transdermal melatonin delivery system |
| 01/26/1995 | WO1995002397A1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 01/26/1995 | DE4412629A1 Nucleic acid transfer peptides and their use for including nucleic acids in eucaryotic cells |
| 01/26/1995 | CA2167153A1 Prodrugs of protein tyrosine kinase inhibitors |
| 01/26/1995 | CA2166875A1 Transferrin receptor specific ligand-neuro-pharmaceutical agent fusion proteins |
| 01/26/1995 | CA2165537A1 Metal radionuclide labeled proteins for diagnosis and therapy |
| 01/25/1995 | EP0635531A2 Liquid copolymers of epsilon-caprolactone and lactide |
| 01/25/1995 | EP0635272A1 Liquid absorbable copolymers for parenteral applications |
| 01/25/1995 | EP0635265A1 Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acid |
| 01/25/1995 | EP0635261A1 Coated microparticles with improved drug absorption |
| 01/25/1995 | EP0635260A1 Oil-based transparent gels |
| 01/25/1995 | EP0635218A1 Taste modifying method and bitter taste reducing method |
| 01/25/1995 | EP0635030A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/$i(neu)) RELATED SURFACE ANTIGENS |
| 01/25/1995 | EP0635029A1 Cartilage matrix protein and methods for use |
| 01/25/1995 | EP0635027A1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis |
| 01/25/1995 | EP0635016A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof |
| 01/25/1995 | EP0634939A1 A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| 01/25/1995 | EP0634938A1 Immunotoxins directed against cd33 related surface antigens |
| 01/25/1995 | EP0634926A1 Composition for therapeutic or diagnostic use, process for its preparation and its use |
| 01/25/1995 | EP0600875A4 Purification of recombinant apolipoprotein e from bacteria. |
| 01/25/1995 | EP0510165B1 Amphiphilic non-ionic, glycerol-derived compounds, a method for preparing same, corresponding intermediate compounds and compositions containing said compounds |
| 01/25/1995 | EP0487674B1 Injectable slow-release galenical |
| 01/25/1995 | CN1097767A Mitomycin C-dextran and its preparing method |
| 01/25/1995 | CN1097597A Cyclosporin soft capsule composition |
| 01/25/1995 | CN1097595A Coated pharmaceutical preparation |
| 01/25/1995 | CN1097593A Aqueous drug composition having property of reversible thermosetting gelation |
| 01/24/1995 | US5384401 Chemical product usable as a non-radioactive carrier |
| 01/24/1995 | US5384400 Esters of pectic and pectinic acid |
| 01/24/1995 | US5384334 Alkoxylated alkyl glucoside ether quaternaries useful in personal care |
| 01/24/1995 | US5384333 Time release agents |
| 01/24/1995 | US5384323 Stabilized dopaminergic compositions |
| 01/24/1995 | US5384133 Inhalants, controlled release |
| 01/24/1995 | US5384132 Stabilized gonadotropin containing preparations |
| 01/24/1995 | US5384130 Drug delivery |
| 01/24/1995 | US5384125 Burn dressing |
| 01/24/1995 | US5384114 Opacifier for water-based compositions |
| 01/24/1995 | CA1334074C Pharmaceutical composition containing high drug load and method for preparing same |
| 01/21/1995 | CA2128361A1 Liquid absorbable copolymers for parenteral applications |
| 01/21/1995 | CA2128360A1 Liquid copolymers of epsilon-caprolactone and lactide |
| 01/19/1995 | WO1995002065A1 Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
| 01/19/1995 | WO1995002057A1 Protein tyrosine kinase and ligands thereof |
| 01/19/1995 | WO1995001806A1 Pro-cytotoxic drug conjugates for anticancer therapy |
| 01/19/1995 | WO1995001802A1 Growth differentiation factor-7 |
| 01/19/1995 | WO1995001788A1 Methods and articles for administering drug to the oral cavity |
| 01/19/1995 | WO1995001786A1 Pharmaceutical compositions for hardly soluble active substances |
| 01/19/1995 | WO1995001785A1 Pharmaceutical compositions for hardly soluble active substances |
| 01/19/1995 | WO1995001783A1 New pharmaceutical formulation |
| 01/19/1995 | WO1995001782A2 Method for making freeze dried drug dosage forms |
| 01/19/1995 | WO1995001774A1 Method and composition for treatment of abnormal conditions of the epithelium of bodily orifices |
| 01/19/1995 | WO1994024983A3 Ocular delivery of nucleic acid |
| 01/19/1995 | WO1994023688A3 Cosmetic and medicinal topical preparations |
| 01/19/1995 | DE4341794C1 Cosmetic and/or pharmaceutical compositions with improved skin feel |
| 01/19/1995 | DE4324014A1 Process for the production of a composition which can be reconstituted in water |
| 01/19/1995 | CA2166798A1 Pro-cytotoxic drug conjugates for anticancer therapy |
| 01/19/1995 | CA2165778A1 Growth differentiation factor-7 |
| 01/19/1995 | CA2164100A1 Pharmaceutical preparations for poorly-soluble active agents |
| 01/18/1995 | EP0634166A1 Drug compositions containing coated, poorly watersoluble drugs for use in pharmaceutical inhalation forms and method to produce them |
| 01/18/1995 | EP0633945A1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN |
| 01/18/1995 | EP0633933A1 Leucine zippers |
| 01/18/1995 | EP0633905A1 Biodegradable polycarbonates and their use as drug carriers |
| 01/18/1995 | EP0633788A1 Methods and compositions for magnetic resonance imaging |
| 01/18/1995 | EP0633787A1 Pharmaceutical composition |
| 01/18/1995 | EP0633783A1 Rapamycin formulation for iv injection |
| 01/18/1995 | EP0633777A1 Parenteral solutions containing 3-dialkylaminoethoxybenzoyl-benzofurans |
| 01/18/1995 | EP0633774A1 Topical administration of toremifene and its metabolites |
| 01/18/1995 | EP0633769A1 Methods of manufacturing high dosage glutathione, the tablets and capsules produced thereby |
| 01/18/1995 | EP0633766A1 Moisturizer |
| 01/18/1995 | EP0563112B1 Enhanced bioavailability pharmaceutical composition containing probucol |
| 01/17/1995 | US5382657 Peg-interferon conjugates |
| 01/17/1995 | US5382601 Memantine-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 01/17/1995 | US5382574 Diabetes |
| 01/17/1995 | US5382571 Clathrates of peroxyacids, their preparation and their uses |
| 01/17/1995 | US5382468 Biodegradable magnetic microclusters and methods for making them |
| 01/17/1995 | US5382434 Low steroid dose dry pharmaceutical preparation |
| 01/17/1995 | CA1334001C Stable pharmaceutical composition containing esmolol |
| 01/17/1995 | CA1333997C Cholesterol-lowering combination compositions of guar gum and niacin |
| 01/16/1995 | CA2128034A1 Drug formulations comprising coated, very sparingly water-soluble drugs for inhalational pharmaceutical forms, and process for their preparation |
| 01/12/1995 | WO1995001568A1 Immunoassay for soluble fibrin polymers |
| 01/12/1995 | WO1995001448A1 A method for introducing a biological substance into a target |
| 01/12/1995 | WO1995001434A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | WO1995001186A1 Drug system |
| 01/12/1995 | WO1995001185A1 Stabilized pharmaceutical peptide compositions |
| 01/12/1995 | WO1995001167A2 Incorporating poly-n-vinyl amide in a transdermal system |
| 01/12/1995 | WO1995001166A1 Encapsulated medicine |
| 01/12/1995 | WO1995001162A1 Pharmaceutical emulsions containing bioactive steroids |
| 01/12/1995 | WO1995001160A1 Stable topical retinoid compositions |
| 01/12/1995 | WO1995001155A1 Oral compositions |
| 01/12/1995 | WO1995001154A1 Oral care compositions |
| 01/12/1995 | WO1995001096A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
| 01/12/1995 | CA2166386A1 Immunoassay for soluble fibrin polymers |